대퇴골두 인공 관절 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the femoral head prostheses market size is expected to increase from USD 1.8 billion in 2025 to USD 1.89 billion in 2026 and reach USD 2.41 billion by 2031, growing at a CAGR of 5.03% over 2026-2031.

This report is Segmented by Product Type (Bipolar, Unipolar/Endocephalic, Modular), Material (CoCr Alloy, Stainless Steel, Ceramic, Oxidized Zirconium), Fixation (Cemented, Cementless, Hybrid), Procedure (Hemiarthroplasty-FNF, Necrosis, THA, Revision), End User (Hospitals, Ascs, Specialty Centers), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Forecasts in Value (USD).

Global Femoral Head Prostheses Market Trends and Insights

Rising Displaced Femoral Neck Fracture Burden In Aging Population

The femoral head prostheses market continues to find strong support from the aging global population, as the incidence of fractures rises steadily despite funding fluctuations. A 2025 analysis highlighted a global age-standardized prevalence rate of 1,834.14 per 100,000 in 2024, reflecting a 14.2% increase from 1990 levels. The study projected 16.8 million global hip fracture cases by 2036, driven by population aging and growth. In the United States, hip fractures currently affect over 250,000 individuals annually, with projections reaching 500,000 by 2050, ensuring consistent demand for fracture-related implants. T

Arthroplasty Preference Over Fixation For Unstable Fractures

The femoral head prostheses market benefits from a clear shift toward arthroplasty for unstable fractures. A 2025 review of 20 systematic studies involving 29,980 patients showed that Total Hip Arthroplasty (THA) reduced revision risk by 33% and improved early functionality compared to hemiarthroplasty, despite a 20-minute longer surgery. Hemiarthroplasty remains relevant for older patients with limited mobility due to shorter operation times and reduced anesthesia exposure. Bipolar implants are increasingly used in patients over 75 with higher frailty and comorbidities. In 2023, partial arthroplasty accounted for 44.5% of femoral neck fracture treatments in Italy, reflecting a selective role for hemiarthroplasty within the market.

Total Hip Arthroplasty And Dual-Mobility Substitution In Fitter Elderly

Healthier elderly patients are increasingly choosing Total Hip Arthroplasty (THA) and dual-mobility constructs, driving demand in the femoral head prostheses market. A 2025 systematic review and meta-analysis highlighted that dual-mobility THA demonstrated superior functional outcomes and fewer long-term complications compared to bipolar hemiarthroplasty in select geriatric femoral neck fracture cases. This trend is most evident among active patients aged 60 to 79, who are cognitively intact and prioritize minimizing revision risks over their extended lifespan. Surgeons are now more proactive in addressing the acetabulum in these patients to mitigate potential cartilage wear or future conversion challenges.

Other drivers and restraints analyzed in the detailed report include:

1. Cemented Stem Adoption In Osteoporotic Fracture Care
2. Faster-Recovery Surgical Workflows And Muscle-Sparing Approaches
3. Tender-Driven Pricing Pressure And Bundled Trauma Episode Economics

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, bipolar femoral head prostheses held 62.10% of the market share, maintaining their leadership in displaced femoral neck fracture care. Their clinical advantages, including shorter procedures and reduced acetabular wear, make them ideal for elderly patients. Unipolar and endocephalic devices remain relevant in cost-sensitive markets, while modular components, projected to grow at 6.90% CAGR through 2031, gain traction for their intraoperative flexibility and ability to address revision complexities.

Cobalt-chromium alloy accounted for 48.85% of the market share by material in 2025, driven by its cost-effectiveness and surgeon familiarity. Stainless steel continues to decline in favor of materials with better long-term performance. Ceramic, forecasted to grow at 7.20% CAGR through 2031, is gaining popularity for its lower wear and revision risks, particularly among younger, active patients. The market is shifting towards proven materials with validated outcomes and consistent manufacturing standards.

Geography Analysis

In 2025, North America held a 41.95% share of the femoral head prostheses market, driven by premium implant demand and clinical adoption. The United States led this trend due to a high incidence of hip fractures, established arthroplasty reimbursements, and rapid surgeon adoption of validated implants. Age-adjusted mortality from femoral neck fractures in the United States declined from 39.6 per 100,000 in 2002 to 22.4 per 100,000 in 2023. Improved outcomes have increased the focus on revision management, material choice, and survivorship. Canada and Mexico contributed smaller shares, with Mexico benefiting from medical tourism by price-sensitive United States patients.

Asia-Pacific is projected to grow at a CAGR of 8.30% through 2031, making it the fastest-growing region in the femoral head prostheses market. Aging populations in China, Japan, and South Korea, along with expanding surgical capacity in India and Southeast Asia, are driving growth. The region's unmet needs mean even modest improvements in diagnosis, trauma referrals, and operating capacity can significantly boost procedure volumes. In China, stricter implant classifications are improving supplier quality but may delay market entry for new players.

Europe remains a key market for femoral head prostheses, supported by mature arthroplasty pathways, widespread cemented fracture care, and strong registry systems. Western Europe favors validated implant platforms, while Eastern Europe offers growth potential in cost-sensitive cemented trauma procedures. In South America, Brazil dominates the market, with suppliers focusing on price-conscious demand through scaled distribution. The Middle East and Africa contribute a smaller share, but GCC investments in specialized orthopedic centers are creating opportunities for high-value cases.

1. AK Medical Holdings Limited
2. B. Braun
3. Beznoska, s.r.o.
4. Corin Group Limited
5. Enovis Corporation
6. Exactech
7. implantcast GmbH
8. Johnson & Johnson MedTech (DePuy Synthes)
9. Mathys Ltd Bettlach
10. Medacta Group SA
11. Meril Life Science
12. MicroPort
13. Ortho Development Corporation
14. Peter Brehm GmbH
15. Smiths Group
16. Stryker
17. Surgival Co., S.A.U.
18. United Orthopedic Corporation
19. Waldemar Link
20. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Displaced Femoral Neck Fracture Burden in Aging Populations
  • 4.2.2 Arthroplasty Preference Over Fixation for Unstable Fractures
  • 4.2.3 Cemented Stem Adoption in Osteoporotic Fracture Care
  • 4.2.4 Faster-Recovery Surgical Workflows and Muscle-Sparing Approaches
  • 4.2.5 Registry-Led Shift Toward Validated Stem and Head Platforms
  • 4.2.6 SKU Renewal from MDR Recertification Favoring Scaled Suppliers
• 4.3 Market Restraints
  • 4.3.1 Total Hip Arthroplasty and Dual-Mobility Substitution in Fitter Elderly Patients
  • 4.3.2 Tender-Driven Pricing Pressure and Bundled Trauma Episode Economics
  • 4.3.3 MDR Recertification Cost and Portfolio Rationalization
  • 4.3.4 Medico-Legal Overhang on Taper and Head-Related Failures
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Bipolar Femoral Head Prostheses
  • 5.1.2 Unipolar / Endocephalic Femoral Head Prostheses
  • 5.1.3 Modular Femoral Head Components
• 5.2 By Material
  • 5.2.1 Cobalt-Chromium Alloy
  • 5.2.2 Stainless Steel
  • 5.2.3 Ceramic
  • 5.2.4 Oxidized Zirconium and Advanced Bearing Surfaces
• 5.3 By Fixation Compatibility
  • 5.3.1 Cemented-Compatible Systems
  • 5.3.2 Cementless-Compatible Systems
  • 5.3.3 Hybrid / Convertible Systems
• 5.4 By Procedure Type
  • 5.4.1 Hemiarthroplasty for Displaced Femoral Neck Fracture
  • 5.4.2 Hemiarthroplasty for Femoral Head Necrosis
  • 5.4.3 Total Hip Arthroplasty
  • 5.4.4 Revision Hip Arthroplasty and Hemi-to-Total Conversion
• 5.5 By End User
  • 5.5.1 Hospitals
  • 5.5.2 Ambulatory Surgical Centers
  • 5.5.3 Specialty Orthopedic Centers
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 India
    • 5.6.3.3 Japan
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 AK Medical Holdings Limited
  • 6.3.2 B. Braun Melsungen AG
  • 6.3.3 Beznoska, s.r.o.
  • 6.3.4 Corin Group Limited
  • 6.3.5 Enovis Corporation
  • 6.3.6 Exactech, Inc.
  • 6.3.7 implantcast GmbH
  • 6.3.8 Johnson & Johnson MedTech (DePuy Synthes)
  • 6.3.9 Mathys Ltd Bettlach
  • 6.3.10 Medacta Group SA
  • 6.3.11 Meril Life Sciences Pvt. Ltd.
  • 6.3.12 MicroPort Scientific Corporation
  • 6.3.13 Ortho Development Corporation
  • 6.3.14 Peter Brehm GmbH
  • 6.3.15 Smith & Nephew plc
  • 6.3.16 Stryker Corporation
  • 6.3.17 Surgival Co., S.A.U.
  • 6.3.18 United Orthopedic Corporation
  • 6.3.19 Waldemar Link GmbH & Co. KG
  • 6.3.20 Zimmer Biomet Holdings, Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment